Roche Holding AG (ROP) Stock Price, Fundamentals & Analysis
Price
360.3 CHF
-0.85%
Last trade: Sep 25, 2026, 05:30 PM GMT+2
Updated: Sep 27, 2026, 11:47 AM GMT+2
Price history
Over the past year ROP traded between 253.5 CHF and 375.6 CHF, closing at 360.3 CHF on Sep 25, 2026.
Key statistics
| Market cap | 287.07B CHF |
|---|---|
| P/E ratio (TTM) | 23.5 |
| Forward P/E | 16.4 |
| EPS (TTM) | 15.31 CHF |
| Dividend yield | 2.72% |
| Annual dividend | 9.8 CHF |
| Ex-dividend date | Mar 12, 2026 |
| Payout ratio | 64% |
| 52-week range | 252.7 – 375.8 |
| 52-week change | 41.9% |
| Beta | 0.35 |
| Price / book | 8.78 |
| Revenue (TTM) | 62.96B CHF |
| Revenue growth (YoY) | -1.2% |
| Gross margin | 74.2% |
| Operating margin | 36.2% |
| Profit margin | 19.6% |
| Return on equity | 38.1% |
| Debt / equity | 90.7 |
| Volume | 677,622 |
| Average volume | 894,533 |
| Exchange | Swiss |
Profile
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- Headquarters
- Basel, Switzerland
- Website
- roche.com
Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand. The company offers pharma solutions in the therapeutic areas of anaemia, blood and solid tumors, dermatology, haematology, infectious diseases, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation. It also provides in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and others; diagnostic instruments; and digital health solutions. Roche Holding AG has a collaboration agreement with Excalipoint Therapeutics to evaluate EXP011 in DLL3-expressing solid tumors. The company was founded in 1896 and is based in Basel, Switzerland.
Overview
Roche Holding AG (ROP) is a stock traded on SIX Swiss Exchange in the Healthcare sector. Currently, the current price is 360.3 CHF, market capitalisation is 287.07B CHF, the trailing P/E is 23.5, the dividend yield is 2.72%. The 52-week price range is 252.7 – 375.8.
A detailed overview for this security is being prepared.
Latest news & filings
No recent headlines.
Related
More on ROP
Track ROP in your portfolio
Hold ROP at XTB, IBKR, Tradeville, Revolut or Trading 212? InvestPane brings every broker into one dashboard — allocation, performance and dividends in one place.
Start free